Tower Research Capital LLC (TRC) - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 50 filers reported holding ATYR PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2018$0
-100.0%
100
-99.3%
0.00%
-100.0%
Q1 2018$40,000
-2.4%
14,956
+27.0%
0.00%
-40.0%
Q4 2017$41,000
+1950.0%
11,777
+948.7%
0.01%
Q4 2016$2,000
-50.0%
1,123
-25.6%
0.00%
Q3 2016$4,000
-50.0%
1,509
-48.2%
0.00%
-100.0%
Q2 2016$8,0002,911
+291000.0%
0.00%
Q1 2016$0
-100.0%
1
-99.9%
0.00%
-100.0%
Q3 2015$12,000
+1100.0%
1,215
+1520.0%
0.00%
Q2 2015$1,000750.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$18,755,00012.78%
EcoR1 Capital, LLC 840,462$8,623,0003.92%
Rock Springs Capital Management LP 388,996$3,991,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 209,027$2,145,0000.27%
Baker Brothers Advisors 2,335,125$23,958,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$4,735,0000.18%
TIVERTON ASSET MANAGEMENT LLC 472,236$4,845,0000.11%
RS INVESTMENT MANAGEMENT CO LLC 1,082,249$11,104,0000.10%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$4,262,0000.07%
Magnetar Financial LLC 354,659$3,639,0000.05%
View complete list of ATYR PHARMA INC shareholders